ALDN.F Stock Overview
Through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Aladdin Healthcare Technologies SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.014 |
| 52 Week High | €0.037 |
| 52 Week Low | €0.014 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -97.91% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| ALDN.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -0.2% |
| 1Y | n/a | -3.2% | 25.6% |
Return vs Industry: Insufficient data to determine how ALDN.F performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how ALDN.F performed against the US Market.
Price Volatility
| ALDN.F volatility | |
|---|---|
| ALDN.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 10.4% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: ALDN.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ALDN.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 3 | Wade Menpes-Smith | www.aladdinid.com |
Aladdin Healthcare Technologies SE, through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology. It specializes in technologies, such as blockchain, machine learning, and artificial intelligence. The company engages in the research and development of Artificial Intelligence Early Diagnosis, an artificial intelligence powered data analysis platform for brain imaging; Health Risk Assessment platform that assesses the risk of cardiovascular, as well as diabetes and kidney related diseases in patients; and Artificial Intelligence assisted Drug Discovery platform to identify various small molecule drug compounds with multiple age-related diseases, including Alzheimer’s, Parkinson's, and SARS-CoV-2.
Aladdin Healthcare Technologies SE Fundamentals Summary
| ALDN.F fundamental statistics | |
|---|---|
| Market cap | US$291.98k |
| Earnings (TTM) | US$12.35k |
| Revenue (TTM) | US$490.42k |
0.0x
P/E Ratio0.0x
P/S RatioIs ALDN.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALDN.F income statement (TTM) | |
|---|---|
| Revenue | €490.42k |
| Cost of Revenue | €190.13k |
| Gross Profit | €300.29k |
| Other Expenses | €287.94k |
| Earnings | €12.35k |
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ALDN.F perform over the long term?
See historical performance and comparison